ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 88 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,503 | -4.4% | 13,466 | +33.6% | 0.00% | – |
Q1 2023 | $10,984 | -37.1% | 10,077 | -15.8% | 0.00% | – |
Q4 2022 | $17,463 | +34.3% | 11,961 | -1.0% | 0.00% | – |
Q3 2022 | $13,000 | -27.8% | 12,085 | +12.7% | 0.00% | – |
Q2 2022 | $18,000 | -37.9% | 10,724 | -24.5% | 0.00% | – |
Q1 2022 | $29,000 | -59.7% | 14,203 | -26.5% | 0.00% | – |
Q4 2021 | $72,000 | -52.3% | 19,315 | -34.0% | 0.00% | – |
Q3 2021 | $151,000 | +45.2% | 29,273 | +19.4% | 0.00% | – |
Q2 2021 | $104,000 | +4.0% | 24,520 | +30.1% | 0.00% | – |
Q1 2021 | $100,000 | -11.5% | 18,840 | -10.3% | 0.00% | – |
Q4 2020 | $113,000 | +232.4% | 21,005 | -6.6% | 0.00% | – |
Q3 2019 | $34,000 | -64.6% | 22,483 | -5.8% | 0.00% | -100.0% |
Q2 2019 | $96,000 | -17.9% | 23,863 | -12.5% | 0.00% | 0.0% |
Q1 2019 | $117,000 | -21.5% | 27,268 | +5.1% | 0.00% | 0.0% |
Q4 2018 | $149,000 | -59.4% | 25,944 | -4.2% | 0.00% | -50.0% |
Q3 2018 | $367,000 | +11.9% | 27,090 | -1.9% | 0.00% | 0.0% |
Q2 2018 | $328,000 | -2.7% | 27,606 | -8.0% | 0.00% | 0.0% |
Q1 2018 | $337,000 | +60.5% | 30,005 | -4.7% | 0.00% | +100.0% |
Q4 2017 | $210,000 | – | 31,484 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 1,377,294 | $5,165,000 | 4.93% |
Long Focus Capital Management, LLC | 4,429,491 | $9,125,000 | 1.17% |
Endurant Capital Management LP | 2,160,890 | $4,451,000 | 1.17% |
NEA Management Company, LLC | 17,082,611 | $35,190,000 | 1.02% |
Matrix Capital Management Company, LP | 38,974,185 | $80,287,000 | 0.96% |
Key Client Fiduciary Advisors, LLC | 420,447 | $866,000 | 0.68% |
ACT CAPITAL MANAGEMENT, LLC | 90,000 | $185,000 | 0.20% |
DAFNA Capital Management LLC | 351,064 | $723,000 | 0.19% |
PFM Health Sciences, LP | 2,374,674 | $4,892,000 | 0.18% |
Rock Springs Capital Management LP | 2,297,194 | $4,732,000 | 0.12% |